Recombinant human IGF-1 ( DrugBank: - )

2 diseases

ID	Disease name (Link within this page)	Number of trials
78	Hypopituitarism	1
299	Cystic fibrosis	1

78. Hypopituitarism

Clinical trials : 492 / Drugs : 341 - (DrugBank : 47) / Drug target genes : 45 - Drug target pathways : 100

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00684957 (ClinicalTrials.gov)	January 2008	23/5/2008	Differential Effects of rhGH vs. rhIGF-1 on Cardiovascular Risk Factors	Differential Effects of rhGH vs. rhIGF-1 on Cardiovascular Risk Factors in Adult Patients With Growt ...	Growth Hormone Deficiency	Drug: Recombinant Human Growth Hormone;Drug: Recombinant human IGF-1	Columbia University	Tercica	Terminated	25 Years	65 Years	Male	5	N/A	United States

Clinical trials : 1,695 / Drugs : 1,527 - (DrugBank : 268) / Drug target genes : 111 - Drug target pathways : 174

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00566241 (ClinicalTrials.gov)	June 2008	30/11/2007	IGF-1 Therapy in Patients With Cystic Fibrosis	An Investigation Into the Use of IGF-1 Therapy in Patients With Cystic Fibrosis	Cystic Fibrosis	Drug: recombinant human IGF-1;Drug: Placebo	Stony Brook University	NULL	Terminated	18 Years	N/A	Both	15	Phase 1	United States